We've detected you are connected Internet Explorer. For the champion Barrons.com experience, delight update to a modern browser.
This transcript is for your personal, non-commercial usage only. To bid presentation-ready copies for organisation to your colleagues, clients oregon customers sojourn http://www.djreprints.com.
https://www.barrons.com/articles/cathie-woods-ark-funds-crispr-51634129432
Oct. 13, 2021 8:52 americium ET
- Order Reprints
- Print Article
Crispr Therapeutics banal was tumbling Wednesday, aft the results of an experimental attraction from the gene-based medicine specializer underwhelmed investors.
That is atrocious quality for high-profile capitalist Cathie Wood, whose Ark Investment Management precocious bought shares successful the biotech institution for 2 of its actively managed exchange-traded funds (ETFs).
The...
Cathie Wood’s Ark Funds Built Up Big Stakes successful Crispr. The Stock Is Now Tumbling.
Crispr Therapeutics banal was tumbling Wednesday, aft the results of an experimental attraction from the gene-based medicine specializer underwhelmed investors.
An mistake has occurred, delight effort again later.
Thank you
This nonfiction has been sent to
Copyright ©2021 Dow Jones & Company, Inc. All Rights Reserved
This transcript is for your personal, non-commercial usage only. Distribution and usage of this worldly are governed by our Subscriber Agreement and by copyright law. For non-personal usage oregon to bid aggregate copies, delight interaction Dow Jones Reprints astatine 1-800-843-0008 oregon sojourn www.djreprints.com.
/etf_analysis_proshares_ultrapro_nasdaq_biotech__ss-5bfc3af846e0fb0051c1e7d5.jpg)
English (US) ·